Director/PDMR Shareholding
GSK plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Sir Jonathan Symonds
b)
Position/status
Non-Executive Chair
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
b)
Nature of the transaction
Purchase of 1,550 Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£19.3524
1,550
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2026-06-19
f)
Place of the transaction
London Stock Exchange (XLON)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Elizabeth (Liz) McKee Anderson
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADS')
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 789 ADS
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$50.6908
789
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2026-06-22
f)
Place of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Charles Bancroft
b)
Position/status
Senior Independent Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADS')
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 1,855 ADS
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$50.6908
1,855
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2026-06-22
f)
Place of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Anne Beal
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADS')
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 745 ADS
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$50.6908
745
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2026-06-22
f)
Place of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Hal Dietz
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADS')
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 667 ADS
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$50.6908
667
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2026-06-22
f)
Place of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Jeannie Lee
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADS')
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 802 ADS
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$50.6908
802
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2026-06-22
f)
Place of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Vishal Sikka
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADS')
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 1,266 ADS
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$50.6908
1,266
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2026-06-22
f)
Place of the transaction
New York Stock Exchange (XNYS)
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
Registered in England & Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHSEMSADEMSEEM
